Ann Pediatr Endocrinol Metab Search

CLOSE


Search

  • HOME
  • Search
Denosumab use in osteogenesis imperfecta: an update on therapeutic approaches
Fatma Majdoub, Hanene Lassoued Ferjani, Dorra Ben Nessib, Dhia Kaffel, Kaouther Maatallah, Wafa Hamdi
Ann Pediatr Endocrinol Metab. 2023;28(2):98-106.   Published online June 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta
Yunha Choi, Soojin Hwang, Gu-Hwan Kim, Beom Hee Lee, Han-Wook Yoo, Jin-Ho Choi
Ann Pediatr Endocrinol Metab. 2022;27(1):22-29.   Published online January 25, 2022
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Successful Pamidronate Treatment of Osteogenesis Imperfecta Type III Infant with Multiple Fractures.
Ju Hee Yoon, Jong Uk Baek, Eun Jung Shim, Il Tae Hwang
Ann Pediatr Endocrinol Metab. 2012;17(3):194-197.
PDFPDF    
  • Journal Impact Factor 2.8
  • SCImago Journal & Country Rank
  • templates


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
501-107, 30 Seocho-daero 74-gil, Seocho-gu, Seoul 06622, Republic of Korea
Tel: +82-2-3471-4268    Fax: +82-2-3471-4269    E-mail: editor@e-apem.org                

Copyright © 2024 by Korean Society of Pediatric Endocrinology.

Developed in M2PI

Close layer
prev next